Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Apogee Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 224
- +19 vs. Q4 2025
- Shares held
- 79.1M
- +12.2M (+18.2%) vs. Q4 2025
- Total value
- $6.64B
- +$1.59B (+31.5%) vs. Q4 2025
- New holders
- 49
- 104 more added
- Sold out
- 30
- 53 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 288 | $8.93B |
| Q1 2026 | 224 | $6.64B |
| Q4 2025 | 207 | $5.27B |
| Q3 2025 | 174 | $2.37B |
| Q2 2025 | 183 | $2.51B |
| Q1 2025 | 169 | $2.30B |
| Q4 2024 | 158 | $2.62B |
| Q3 2024 | 139 | $3.29B |
| Q2 2024 | 139 | $2.13B |
| Q1 2024 | 139 | $3.52B |
| Q4 2023 | 85 | $1.16B |
| Q3 2023 | 73 | $848.7M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Apogee Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 598,902 | $50.4M | 0.04% | −168,079−21.9% | Reduced |
| Goldman Sachs Group Inc | 652,590 | $54.9M | 0.01% | +87,180+15.4% | Added |
| Mercer Global Advisors Inc | 831,428 | $70.0M | 0.10% | −59,237−6.7% | Reduced |
| Alliancebernstein L.P. | 990,297 | $74.7M | 0.02% | −103,360−9.5% | Reduced |
| Bank of America Corp | 900,871 | $75.8M | 0.01% | +107,176+13.5% | Added |
| JPMorgan Chase & Co | 1,110,470 | $87.4M | 0.01% | −262,596−19.1% | Reduced |
| Frontier Capital Management Co LLC | 1,064,483 | $89.6M | 0.92% | +584,030+121.6% | Added |
| Vestal Point Capital, LP | 1,100,000 | $92.6M | 2.59% | +550,000+100.0% | Added |
| Price T Rowe Associates Inc | 1,143,152 | $96.2M | 0.01% | −93,983−7.6% | Reduced |
| UBS Group AG | 1,144,328 | $96.3M | 0.02% | +169,502+17.4% | Added |
| Geode Capital Management, LLC | 1,217,289 | $102.5M | 0.01% | +158,204+14.9% | Added |
| Affinity Asset Advisors, LLC | 1,284,926 | $108.2M | 6.34% | +50,000+4.0% | Added |
| Paradigm Biocapital Advisors LP | 1,348,243 | $113.5M | 2.32% | +225,000+20.0% | Added |
| Perceptive Advisors LLC | 1,540,384 | $129.7M | 2.56% | −790,267−33.9% | Reduced |
| Driehaus Capital Management LLC | 1,920,800 | $161.7M | 1.19% | −262,904−12.0% | Reduced |
| State Street Corp | 2,162,964 | $182.1M | 0.01% | +472,778+28.0% | Added |
| Janus Henderson Group PLC | 2,360,596 | $198.8M | 0.09% | +297,992+14.4% | Added |
| Vanguard Capital Management LLC | 2,502,095 | $210.6M | 0.01% | +2,502,095 | New |
| RTW Investments, LP | 2,782,097 | $234.2M | 2.33% | +70,000+2.6% | Added |
| BlackRock, Inc. | 4,085,651 | $343.9M | 0.01% | +301,657+8.0% | Added |
| Wellington Management Group LLP | 4,375,703 | $368.3M | 0.07% | −370,882−7.8% | Reduced |
| VR Adviser, LLC | 8,493,321 | $714.9M | 26.68% | 00.0% | Unchanged |
| FMR LLC | 9,262,291 | $779.6M | 0.04% | +1,037,253+12.6% | Added |
| T. Rowe Price Investment Management, Inc. | 10,300,984 | $867.0M | 0.60% | +7,568,528+277.0% | Added |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −534,845−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Trails Edge Capital Partners, LP | 0 | $0 | 0.00% | −192,000−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −99,648−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −80,574−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −51,827−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −33,264−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −30,039−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −20,972−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,283−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −12,700−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,192−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −10,910−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −9,101−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −6,371−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −3,466−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,340−100.0% | Sold out |
| Boyer Financial Services, Inc. | 0 | $0 | 0.00% | −3,126−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −3,100−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −2,524−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −2,445−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,210−100.0% | Sold out |
| Antipodes Partners Ltd | 0 | $0 | 0.00% | −723−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −166−100.0% | Sold out |
| Exane Asset Management | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |